HP and cranioectodermal dysplasia: Zonulin is neither specific nor unique to CeD, as other proinflammatory mediators of barrier and tight junction down-regulation, such as tumor necrosis factor A and interferon-g, have been described in active CeD (Schumann et al., 2017).